Ingevity Corporation (NYSE:NGVT – Get Free Report) SVP Ryan Fisher sold 2,709 shares of the business’s stock in a transaction on Monday, August 3rd. The stock was sold at an average price of $73.72, for a total transaction of $199,707.48. Following the transaction, the senior vice president directly owned 15,722 shares in the company, valued at $1,159,025.84. This trade represents a 14.70% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Ingevity Price Performance
Shares of Ingevity stock opened at $75.47 on Wednesday. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. Ingevity Corporation has a fifty-two week low of $45.66 and a fifty-two week high of $79.29. The firm has a fifty day moving average price of $72.03 and a two-hundred day moving average price of $71.13. The company has a market cap of $2.59 billion, a PE ratio of 51.34 and a beta of 1.16.
Ingevity (NYSE:NGVT – Get Free Report) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.41. The company had revenue of $314.10 million for the quarter, compared to the consensus estimate of $312.20 million. Ingevity had a net margin of 4.65% and a return on equity of 284.70%. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. Analysts expect that Ingevity Corporation will post 5.4 EPS for the current year.
Hedge Funds Weigh In On Ingevity
Wall Street Analyst Weigh In
NGVT has been the subject of several recent research reports. Weiss Ratings raised Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a report on Friday. Wall Street Zen lowered Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday. Two research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $80.00.
Check Out Our Latest Stock Analysis on NGVT
About Ingevity
Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.
The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.
Read More
- Five stocks we like better than Ingevity
- System Upgrade: First Internet Bancorp Options Surge
- AI Security Breaches Raise New Risks for Microsoft and Amazon’s Agent Push
- The AI Chip Blockade Is Creating a Shadow Market
- Grab Holdings Stock Forms Bottom After Strong Beat-and-Raise Quarter
Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.
